A new cancer blood test could significantly reduce the need for invasive examinations in women suspected of gynaecological cancer, researchers say.
The PinPoint test employs artificial intelligence (AI) to analyse 30 markers in the blood, predicting a patient’s risk as low, elevated, or high.
